The trial will take place at the University of Alabama at Birmingham and measure the levels of the two drugs in blood and vaginal fluid of healthy women participants, aged 18-45 years.
UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.